PMU14 China's 2019 National Reimbursement Drug LIST Update: Implications on Global and Local Manufacturer Strategy

Abstract

Authors

S. Park M. Hunt A. Du W. Zhang

Full Text Cite This Article
Back to Volume 22, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×